The C-reactive protein test market is growing as healthcare systems place greater emphasis on preventive care, chronic disease management, and early assessment of inflammatory conditions. The market was valued at USD 3.55 billion in 2024 and is projected to reach USD 5.5 billion by 2032, at a CAGR of 5.63%.wiseguyreports C-reactive protein, or CRP, is an inflammatory marker used within broader...